← Retour 🔗 Vue partagée — Acme Corporation · Lecture seule

Engineering Biology Access to Infrastructure Pilot

Innovate UK · UKRI Funding Opportunity · GB
2.0
Score global

Résumé

This call offers UK registered businesses access to funding for Engineering Biology pilot scale and validation projects, with a total budget of up to £5 million. Projects fall within UKRI's Engineering Biology Programme, funded by BIST, with applications closing on 21 October 2026. Specific details on maximum grant per applicant, consortium requirements, and technology readiness levels are not stated in the available information.

Analyse d'adéquation

Engineering Biology is a distinct biotechnology domain focused on synthetic biology and living systems engineering, which has no overlap with Acme Corporation's semiconductor and AI focus. While the call is UK-based and the UK is in the target regions, the sector mismatch is fundamental and disqualifying.

Scores détaillés

Pertinence 2.0/10
Urgence 6.0/10
Adéquation stratégique 1.0/10

Brief exécutif

Low

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

UK registered businesses can apply for a share of up to £5 million for Engineering Biology pilot scale and validation projects. This funding is part of UKRI’s Engineering Biology Programme and funded by BIST.

Source officielle
Voir l'appel ↗